Search
New from SAMHSA: Medications for Opioid Use Disorders
National Trends in Alcohol Consumption in Mexico
Abstract:
Introduction: Worldwide, binge drinking of alcohol has increased, especially among young people. In Mexico, various epidemiological sources allow us to account for the growth this pattern of consumption has had. Given this...
The Influence of Hazardous Drinking on Psychological Functioning, Stress and Sleep during and after Treatment in Patients with Mental Health Problems
Abstract
Objectives: Hazardous drinking could negatively affect health and lead to alcohol use disorders, but it is unclear how hazardous drinking affects treatment outcomes of depression and anxiety and stress-related mental health...
Guide to treatment and social integration in the field of addictions
The aim of this guide is to facilitate the understanding of the problem of adolescent substance use, as well as present practices based on clinical evidence more effective guidance and intervention with this population.
The guide is...
Nabiximols Combined with Motivational Enhancement/Cognitive Behavioral Therapy for the Treatment of Cannabis Dependence
Abstract
Background
The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of promising pharmacotherapy. We previously showed that nabiximols (27 mg/ml Δ9...
Measuring Treatment Outcomes in Gambling Disorders
Abstract
Background and Aims
Considerable variation of outcome variables used to measure recovery in the gambling treatment literature has precluded effective cross-study evaluations and hindered the development of best-practice treatment...
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians
Abstract
Although cannabis use is federally prohibited, medical cannabis is legal in some form in 30 states and the District of Columbia, and recreational use is legal in 8 states and the District of Columbia. The increasing legal...
Reported Theory Use by Digital Interventions for Hazardous and Harmful Alcohol Consumption, and Association with Effectiveness
ABSTRACT
Background: Applying theory to the design and evaluation of interventions is likely to increase effectiveness and improve the evidence base from which future interventions are developed, though few interventions report this.
Obje...
Effectiveness Bank Matrix Cell: Can Medications Make It *Too* Easy to Recover?
Drug-based treatments dominate opiate addiction treatment but are far from universally accepted. Referring to chemical ‘solutions’ to addiction, the ‘bite’ commentary on this cell ends with the “curious possibility that precisely because a...
Intervention guide mhGAP for mental, neurological disorders and substance use in the level of non-specialized health care. Version 2.0
Mental, neurological and substance (MNS) disorders are very common and represent a large burden of disease and disability around the world. There remains a wide gap between the capacity of health systems and resources, between what is...
mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
Overview
This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as...
Women and drug treatment
Guide to clinical advice for treatment and rehabilitation programs in drugs in specific population of adult women.
Are you an ISSUP member? If not, you can join ISSUP by registering here: https://www.issup.net/membership/apply
Are a part...
Certification of Addiction Professionals in Africa: An Overview of the Process in Kenya
Abstract
This paper focuses on Kenya’s course of action to address the drug problem, specifically, treatment and rehabilitation of persons with Substance Use Disorders (SUDs). Treatment and rehabilitation of persons with SUDs was formally...
Supervised Dosing with a Long-Acting Opioid Medication in the Management of Opioid Dependence
Trials challenge the need for the widely accepted policy of making opioid-dependent patients take their methadone or other opioid substitutes at the clinic or pharmacy, but ‘no difference’ findings may be due to the limitations of the...
Recommendations for NIDA's Cannabis Policy Research Agenda
The National Institute on Drug Abuse (NIDA) has released a new report Recommendations for NIDA's Cannabis Policy Research Agenda.
The document has been prepared by the National Advisory Council on Drug Abuse Workgroup which was formed in...
The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and their Associated Neural Mechanisms
In drug addiction, cues previously associated with drug use can produce craving and frequently trigger the resumption of drug taking in individuals vulnerable to relapse. Environmental stimuli associated with drugs or natural reinforcers...
Alcohol and Drugs Prevention, Treatment and Recovery: Why Invest?
Estimates show that in the UK the social and economic costs of alcohol related harm amount to £21.5bn, while harm from illicit drug use costs £10.7bn. These include costs associated with deaths, the NHS, crime and, in the case of alcohol...
A Pocket Guide: investigation of the abuse of alcohol and a brief intervention
This Pocket Guide was summarized Guide 34 pages of the NIAAA, helping patients who drink too much: A guide clinical. Materials include:
- Educational brochures for patients
- Already formatted progress notes
- Animated slideshow for...
Guide for health care professionals - helping patients who drink too much
Guide aimed at professionals of health to work with people from drinking alcohol in excess
This guide has been written for primary care health and mental health professionals. It has been produced by the National Institute on the Alcohol...
Dual Disorders in Individuals under Treatment for both Alcohol and Cocaine
Abstract
Introduction: Descriptive data about co-occurrence of alcohol and cocaine consumption is scarce, despite its important prevalence. Dual disorders show high prevalence in clinical samples, and patients report worse evolution and...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member